3 June 2026 | 10:00–13:00 CEST | In-Person & Online | London

This high-level briefing from the Financial Times, in partnership with Syneos Health, will bring together leading executives and investors to focus on what it takes to succeed in Europe’s launch environment.

The discussions will evaluate ways to sustain capital flows through launch and explore how to scale the next generation of globally competitive biopharma companies.

Join us in-person or online to hear speakers from the Association of the British Pharmaceutical Industry, AM-Pharma, Sofinnova Partners, Medicxi, SV Health Investors and more.

Register here.